Inogen (INGN) CCO reports RSU vesting and 20,000-unit grant

Rhea-AI Filing Summary

Inogen’s Chief Commercial Officer Gregoire Ramade reported equity compensation activity involving restricted stock units and common shares. On March 1, 2026, 13,005 restricted stock units were exercised into 13,005 shares of common stock, and 6,022 shares were withheld at $6.10 per share to cover tax liabilities linked to a vesting award.

On February 27, 2026, Ramade received a new grant of 20,000 restricted stock units, each representing one share of Inogen common stock. One-third of this grant is scheduled to vest on March 1, 2027, with the remaining units vesting in equal annual installments on the same date in subsequent years, subject to continued service.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ramade Gregoire

(Last) (First) (Middle)

C/O INOGEN, INC.

500 CUMMINGS CENTER, SUITE 2800

(Street)

BEVERLY MA 01915

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Inogen Inc [ INGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/01/2026		M		13,005	A	$0	50,251	D
Common Stock	03/01/2026		F		6,022(1)	D	$6.1	44,229	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(2)	02/27/2026		A		20,000		(3)	(3)	Common Stock	20,000	$0	20,000	D
Restricted Stock Unit	(2)	03/01/2026		M		13,005		(4)	(4)	Common Stock	13,005	$0	26,010	D

Explanation of Responses:

1. The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2026.

2. Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

3. Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2027 (the "2027 Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2027 Vesting Commencement Date.

4. 1/3rd of the restricted stock units vested on March 1, 2026 (the "2026 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2026 Vesting Commencement Date.

	/s/ Mary Wright, as Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Inogen (INGN) Chief Commercial Officer Gregoire Ramade report?

Gregoire Ramade reported exercising 13,005 restricted stock units into common stock, a tax-related disposition of 6,022 shares, and receiving a new grant of 20,000 restricted stock units. These actions reflect routine equity compensation activity and related tax withholding.

How many restricted stock units did Inogen (INGN) grant to its Chief Commercial Officer?

Inogen granted Gregoire Ramade 20,000 restricted stock units. Each unit represents a contingent right to receive one share of Inogen common stock, providing additional equity-based compensation tied to continued service and future vesting dates.

What is the vesting schedule for Gregoire Ramade’s new 20,000 RSUs at Inogen (INGN)?

One-third of the 20,000 restricted stock units vests on March 1, 2027, with one-third vesting each year thereafter on the same date. Vesting is conditioned on Ramade’s continued service with Inogen throughout the vesting period.

Why were 6,022 Inogen (INGN) shares disposed of in Gregoire Ramade’s Form 4?

The 6,022 shares were withheld to cover Gregoire Ramade’s tax withholding liability related to a time-based restricted stock award that vested on March 1, 2026. This is a tax-withholding disposition, not an open-market sale of shares.

What does each restricted stock unit represent in the Inogen (INGN) Form 4 filing?

Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. The units convert into shares as they vest over time, subject to the executive’s continued service with the company.

How did Gregoire Ramade’s direct common stock holdings in Inogen (INGN) change after these transactions?

Following the derivative exercise and tax-withholding disposition, Gregoire Ramade directly held 44,229 shares of Inogen common stock. This reflects both the shares received from RSU conversion and the shares withheld to satisfy tax obligations.